cancer biomarker problem
genomic technologies offer promise comprehensive understanding cancer technologies used characterize tumours molecular level several clinical successes shown information can guide design drugs targeted relevant molecule one main barriers progress identifying biological indicators biomarkers cancer predict will benefit particular targeted therapy
